Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

PREMARIN Drug Profile

« Back to Dashboard

Which patents cover Premarin, and what substitute generic drugs are available?

Premarin is a drug marketed by Wyeth Pharms Inc and is included in three NDAs.

The generic ingredient in PREMARIN is estrogens, conjugated. There are three drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the estrogens, conjugated profile page.

Summary for Tradename: PREMARIN

Patents:0
Applicants:1
NDAs:3
Suppliers / Packagers: see list10
Bulk Api Vendors: see list25
Clinical Trials: see list17
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PREMARIN at DailyMed

Pharmacology for Tradename: PREMARIN

Ingredient-typeEstrogens, Conjugated (USP)
Drug ClassEstrogen
Mechanism of ActionEstrogen Receptor Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
INJECTABLE;INJECTION010402-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-006Jul 16, 2003RXYesNo► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
CREAM;TOPICAL, VAGINAL020216-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PREMARIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
CREAM;TOPICAL, VAGINAL020216-001Approved Prior to Jan 1, 19825,210,081► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-003Approved Prior to Jan 1, 19825,210,081► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-002Approved Prior to Jan 1, 19825,210,081► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-001Approved Prior to Jan 1, 19825,210,081► Subscribe
Wyeth Pharms Inc
PREMARIN
estrogens, conjugated
TABLET;ORAL004782-004Approved Prior to Jan 1, 19825,210,081► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc